Ameritas Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

Ameritas Advisory Services's BMY Position: Q2 2026 in Review

Ameritas Advisory Services increased its Bristol-Myers Squibb (BMY) stake by 53% in Q2 2026, buying an estimated $294K and bringing the position to 14,839 shares worth $855K. The position accounts for 0.02% of the portfolio, ranked #605.

Ameritas Advisory Services first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.54M in Q4 2022. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Ameritas Advisory Services held 14,839 shares of Bristol-Myers Squibb worth $855K as of Q2 2026.
• Ameritas Advisory Services bought 5,121 Bristol-Myers Squibb shares in Q2 2026, an estimated $294K.
• Bristol-Myers Squibb made up 0.02% of Ameritas Advisory Services's portfolio in Q2 2026, its #605 holding.
• Ameritas Advisory Services first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
• Ameritas Advisory Services's Bristol-Myers Squibb position peaked at $1.54M in Q4 2022.
• 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.